Cancer Research eNews - 1st Edition Tue, 2009-10-06
Summary:
This edition of Novus Cancer eNews includes a spotlight on Beclin 1, newly conjugation Carbonic Anhydrase IX antibodies, as well as recently published papers citing antibodies manufactured by Novus.
Date:
Tue, 2009-10-06
Cancer News
-
CANCER NEWSLETTER - 1st Edition
Spotlight on Beclin 1 Beclin 1 is the first identified mammalian gene to mediate autophagy and also has tumor suppressor and antiviral function. Autophagy, a process of bulk protein degradation through an autophagosomic-lysosomal pathway, is important for differentiation, survival during nutrient deprivation, and normal growth control, and is often defective in tumor cells. Expression of the Beclin 1 protein is frequently decreased in malignant breast epithelial cells. Based upon these observations, it is speculated that Beclin 1 may work through induction of autophagy to negatively regulate tumorigenesis and to control viral infections.
Coming Soon: Customer Reviews Published on our Website GAPDH Antibody [NB300-221]
This antibody was given 5 stars in a customer review submitted June 4, 2009. The customer used the antibody in Western Blot on EAhy926 cell lysate at a dilution of 1:5,000. A band was visualized at 30-40 kDa. The customer praised the specificity of this antibody saying: “We’ve been using this product for many years.”
This antibody was given 4 stars in a customer review submitted March 26, 2009. The customer used the antibody in Western Blot on rat liver whole homogenate and primary hepatocyte cell lysate and detected bands at 31 kDa and 67 kDa.
New Product Information •25% OFF select cancer-related antibodies and proteins. View the list here.
•Carbonic Anhydrase IX is now available conjugated to Dylight 488™, DyLight 549™ and DyLight 649™. View the available Carbonic Anhydrase IX products here.